Clinical Trial Update: Evaluation of the Hypoallergenicity of an Extensively Hydrolyzed Formula [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the hypoallergenicity of an extensively hydrolyzed formula for cow's milk allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Allergy

Drugs mentioned

• Extensively Hydrolyzed Formula (Hypoallergenic) (extensively hydrolyzed cow milk protein formula)

Snippet

Sponsor: United Pharmaceuticals | Conditions: Cow Milk Allergy | Phase 3 | Status: COMPLETED